Bristol-Myers Squibb offers $4.5 billion for ImClone
Bristol-Myers Squibb (BMS) has announced an offer of $60 per share, or roughly $4.5 billion, for the acquisition of ImClone. ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.